Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer

被引:53
作者
Chu, Xiao-Yuan [1 ]
Chen, Long-Bang [1 ]
Wang, Jing-Hua [1 ]
Su, Quan-Sheng [1 ]
Yang, Ji-Rong [1 ]
Lin, Yong [1 ]
Xue, Li-Jun [1 ]
Liu, Xiao-Bei [1 ]
Mo, Xiao-Bei [1 ]
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China
关键词
inhibitor of apoptosis; survivin; colorectal cancer; invasion; metastasis; TARGETING SURVIVIN; RNA INTERFERENCE; UP-REGULATION; INHIBITORS; CELLS;
D O I
10.1002/jso.22134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The aim of this study was to investigate the association of survivin expression with metastasis of colorectal cancer (CRC). Methods: RT-PCR and Western blot assays were performed to detect survivin expression in CRC cells and normal intestinal epithelial cell. The expression of survivin gene was also detected in 15 CRC tissues, surrounding and adjacent colon tissues. Moreover, survivin expression in 48 CRC tissues with or without lymph node metastasis was analyzed. Multivariate analysis for lymph node metastasis was performed using logistic regression model. RNA interference was used to inhibit survivin expression in CRC cells and analyze its effect on invasion and metastasis of CRC cells. Results: The expression levels of survivin mRNA and protein were higher in CRC cells than in normal intestinal epithelial cell line. The average levels of survivin mRNA and protein were higher in CRC tissues than surrounding or adjacent colon tissues (P < 0.05). High survivin expression was an independent factor for predicting lymph node metastasis of CRC (P 0.043). RNAi-mediated survivin knockdown could significantly inhibit in vitro invasion and in vivo metastasis of CRC cells, which might be inactivation of matrix metalloproteinases. Conclusion: Targeting survivin will be a potential strategy to suppress metastasis of CRC. J. Surg. Oncol. 2012; 105: 520-528. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:520 / 528
页数:9
相关论文
共 25 条
[1]  
Chu XY, 2010, HEPATO-GASTROENTEROL, V57, P1445
[2]   Survivin: A promising tumor biomarker [J].
Duffy, Michael J. ;
O'Donovan, Norma ;
Brennan, Donal J. ;
Gallagher, William M. ;
Ryan, Brid M. .
CANCER LETTERS, 2007, 249 (01) :49-60
[3]   Metastasis mechanisms [J].
Geiger, Thomas R. ;
Peeper, Daniel S. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1796 (02) :293-308
[4]   Survivin Expression in Colorectal Carcinomas: Correlations with Clinicopathological Parameters and Survival [J].
Kalliakmanis, J. G. ;
Kouvidou, Ch. ;
Latoufis, C. ;
Kouvatseas, G. ;
Anagnostakis, D. ;
Papatheodoridis, G. ;
Koskinas, J. ;
Archimandritis, A. .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (10) :2958-2964
[5]   Targeting survivin in cancer: patent review [J].
Kanwar, Jagat R. ;
Kamalapuram, Sishir K. ;
Kanwar, Rupinder K. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (12) :1723-1737
[6]   Recent Advances in Anti-Survivin Treatments for Cancer [J].
Kanwar, R. K. ;
Cheung, C. H. A. ;
Chang, J-Y ;
Kanwar, J. R. .
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (15) :1509-1515
[7]   Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells [J].
Knight, Brandi B. ;
Oprea-Ilies, Gabriela M. ;
Nagalingam, Arumugam ;
Yang, Lily ;
Cohen, Cynthia ;
Saxena, Neeraj K. ;
Sharma, Dipali .
ENDOCRINE-RELATED CANCER, 2011, 18 (04) :413-428
[8]   Pathobiology of Colorectal Cancer Hepatic Metastases With an Emphasis on Prognostic Factors [J].
LeGolvan, Mark P. ;
Resnick, Murray .
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (08) :898-908
[9]   Role of survivin and its splice variants in tumorigenesis [J].
Li, F .
BRITISH JOURNAL OF CANCER, 2005, 92 (02) :212-216
[10]   Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation [J].
McKenzie, Jodi A. ;
Liu, Tong ;
Goodson, Agnessa G. ;
Grossman, Douglas .
CANCER RESEARCH, 2010, 70 (20) :7927-7937